| 中文名称 | (2'-(2H-四唑-5-基)-[1,1'-联苯]-4-基)甲醇 |
|---|---|
| 中文别名 | 2-[(1H-四唑-5-基)联苯-4-基]甲醇;厄贝沙坦杂质C;氯沙坦杂质B;洛沙坦杂质B 标准品;2'-(2H-四唑-5-基)-[1,1'-联苯]-4-甲醇;缬沙坦杂质26;氯沙坦EP杂质B;氯沙坦钾EP杂质B |
| 英文名称 | (2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol |
| 英文别名 | 2'-[(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol;2´-[(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol;[1,1'-Biphenyl]-4-methanol, 2'-(2H-tetrazol-5-yl)-;2?-[(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol;[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methanol;Irbesartan Impurity 7;Valsartan Impurity 26;Losartan EP IMpurity B;2'-(1H-Tetrazol-5-yl)-;2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-methanol;Losartan EP IMpurity B (Losartan HydroxyIMpurity );(2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol;LOSARTAN POTASSIUM IMPURITY B [EP IMPURITY];A899334;(2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methanol;UNII-14NFA600H4;DTXSID20166899;AKOS027335464;MFCD18379631;14NFA600H4;[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]-methanol;F50075;Losartan Potassium Imp. B (EP); Losartan Imp. B (EP); [2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol; Losartan Potassium Impurity B; Losartan Impurity B;160514-13-6;ZRQJTHPAIULYJV-UHFFFAOYSA-N;5-(4'-Hydroxymethylbiphenyl-2-yl)-1H-tetrazole;[2'-(2H-1,2,3,4-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL]METHANOL;Losartan potassium impurity B [EP];(2'-(1H-Tetrazol-5-yl)biphenyl-4-yl)methanol;SCHEMBL1773521;(1,1'-Biphenyl)-4-methanol, 2'-(2H-tetrazol-5-yl)-;Q27251639;Losartan EP Impurity B (Losartan Hydroxy Impurity/ Irbesartan Hydroxy Impurity/ Candesartan Hydroxy Impurity);C90688;[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methanol |
| CAS号 | 160514-13-6 |
| 分子式 | C14H12N4O |
| 分子量 | 252.27 |
微信公众号
版权所有：济南迈纳科技有限公司 未经授权禁止拷贝本站资料，如有违反,将追究法律责任
备案号： 鲁ICP备2021031564号-1 危险品化学品经营许可证 营业执照
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
